ORMDL3在哮喘发生中的作用及其转录调控机制研究
[Abstract]:Asthma is a complex disease caused by environmental and genetic factors. The heritability of asthma is about 36% - 79%. In 2007, the first genome-wide association analysis of asthma revealed a new susceptibility gene, ORMDL3. Researchers found that genetic polymorphisms in the 17q21 region of ORMDL3 were significantly associated with childhood asthma. Furthermore, the genetic polymorphism in this region is also closely related to the expression of ORMDL3 gene in the lymphoblastoid cell lines of asthmatic children infected with EBV.
ORMDL3 gene, located at 17q21, is a member of the ORM gene family. In yeast, ORMDL1 and ORMDL2 are members of the ORMDL3 family, while in humans there are three members of the ORMDL3 family. Transsphingomyelin metabolism may play an important role in the development of asthma. In addition, the knockout of ORM gene in yeast may result in slow growth and increased sensitivity to toxic substances. This phenomenon was saved by transfection of human ORMDL3 gene into the mRNA. ORMDL3 gene encodes an endoplasmic reticulum containing 153 amino acids four times across the membrane. ORMDL3 is widely expressed in human tissues, especially in the liver and peripheral blood lymphocytes. Studies have shown that ORMDL3 co-localizes with calcium pumps in the endoplasmic reticulum, inhibits the function of calcium pumps, affects the balance of calcium ions, and promotes endoplasmic reticulum stress and unfolded protein responses, suggesting that ORMDL3 may be involved in endoplasmic reticulum-related inflammation. In addition, genetic polymorphisms in the 17q21 region of cord blood mononuclear cells in children were found to be associated not only with the expression of ORMDL3 and GSDMA genes, but also with the secretion of IL-17, suggesting that the region may be associated with the development and differentiation of T cells in the early stage of immune system maturation. In addition to asthma, the region is associated with human development. ORMDL3 was also found to be significantly associated with various inflammatory diseases such as Crohn's disease, ankylosing spondylitis, systemic lupus erythematosus, type 1 diabetes mellitus, glioma, primary biliary cirrhosis, and allergic rhinitis.
Since ORMDL3 was found to be a new susceptible gene for asthma, it has been tested in a very short period of time in a number of different ethnic groups. It has been found that ORMDL3 gene is significantly associated with childhood asthma in different populations. What about asthma? The genetic polymorphism of 17q21 in EBV-infected asthmatic children's lymphoblasts is associated with the expression of ORMDL3 gene. Is this still present in the peripheral blood lymphocytes of adult asthmatic patients? How is the abnormal expression of ORMDL3 gene in asthmatic patients caused? With these problems, this paper carries out the following four aspects of research:
Part one association analysis between 17q21 area and asthma in Chinese Han Adults
To clarify the relationship between the 17q21 region of ORMDL3 gene and adult asthma, 710 unrelated adult patients with asthma were collected from the Respiratory Department of Qilu Hospital of Shandong University, and 656 unrelated, non-asthmatic and other respiratory diseases and allergies were randomly collected from the Health Examination Center. Based on the related reports and linkage disequilibrium in the Chinese population, five single nucleotide polymorphisms (SNPs) were selected from the 17q21 region: rs7216389, rs12603332, rs12936231, rs9303277, and rs11557467 for population-based case-control association analysis.
The results showed that the five SNP polymorphisms were significantly associated with adult asthma (P 0.05). Two SNP polymorphisms, rs9303277 and rs11557467, had the strongest association with adult asthma (P 0.001). Individuals with the G allele at rs11557467 or the C allele at rs9303277 had a significantly increased risk of asthma (OR = 1.27, 95% CI 1.0). 7-1.51, P = 0.006 and OR = 1.27, 95% CI 1.07-1.49, P = 0.005). Even after removing the influence of sex and age, this correlation still exists. In addition, haplotype analysis showed that CTGTT had protective effect compared with TCCCG, OR = 0.81, 95% CI 0.67-0.97, P = 0.02.97.
Therefore, the results of this study indicate that the genetic polymorphisms in the 17q21 region of ORMDL3 gene are significantly associated with adult asthma in Chinese Han population.
The second part is the identification of functional SNP in asthma caused by 17q21 region.
Because ORMDL3 gene has two transcript forms in the Ensembl database: ENST00000304046 (ORMDL3-001) and ENST00000394169 (ORMDL3-002), and the coding regions of the two transcripts are identical, but the difference is only the untranslated region, so the protein they encode is identical. In addition, Moffatt et al. found that genetic polymorphism in the 17q21 region of the lymphoblastoid cell line of asthmatic children infected with EBV was closely related to the expression level of ORMDL3 gene, suggesting that the abnormal expression of ORMDL3 gene regulated by genetic polymorphism may be involved in the development of asthma. But so far, none of the asthma-related SNPs in this region is located in the coding region of ORMDL3 gene, and the SNP locus rs12603332 selected in the first part of our study happens to be located in the first intron of the gene. It has been reported that the genetic polymorphism in the intron may be affected. Therefore, we first examined the transcriptional form of ORMDL3 gene used in different tissues of the human body and whether the different alleles of rs12603332, a SNP locus in the first intron of the gene, affected the splicing of ORMDL3 gene mRNA.
DNA and RNA were extracted from human liver, esophageal cancer, colorectal cancer and lung tissues, respectively. In addition, primers were designed according to the splicing characteristics of the two transcripts. PCR amplification was used to detect ORMDL. The results showed that ORMDL3 was only expressed in human peripheral blood lymphocytes, liver tissue, esophageal cancer tissue, colorectal cancer tissue and lung tissue in vitro. The first transcript form of the gene: ENST00000304046 (ORMDL3-001), and individuals of either CC genotype or TT genotype (rs12603332 locus) only express the first transcript. Therefore, rs12603332 locus does not affect the splicing of ORMDL3 gene, so what is the mechanism of genetic polymorphism in this region leading to asthma? Is it a real functional site?
Because changes in gene transcription levels are a very important mechanism mediating susceptibility to asthma or other diseases, and gene transcription abundance is likely to be directly affected by some SNP polymorphisms that alter transcription factor binding, we examined the expression of ORMDL3 and GSDMB genes in asthmatic patients and controls. Fresh peripheral blood samples from 61 patients with asthma and 70 normal subjects were collected from the Department of Respiration, Qilu Hospital, Shandong University. DNA and RNA were extracted and analyzed by real-time quantitative PCR. The expression levels of ORMDL3 and GSDMB genes were significantly higher in individuals with rs7216389, rs12603332 and rs12936231 loci than in controls (P 0.05).
Therefore, the results of this study show that: firstly, ORMDL3 gene exists as the first transcript in human peripheral blood lymphocytes, liver, esophageal cancer, colorectal cancer and lung tissues, and the different alleles of rs12603332 in the first intron of ORMDL3 gene do not affect the splicing of ORMDL3 gene mRNA. The expression levels of ORMDL3 and GSDMB genes in peripheral blood lymphocytes of adult asthmatic patients were significantly higher than those of normal controls, and the risk allele of asthma-related genetic polymorphism in 17q21 region could significantly increase the expression levels of these two genes. However, because the 17q21 region is a strong linkage disequilibrium region, screening specific functional sites from it needs more research to confirm.
The third part is the identification of the basic promoter of ORMDL3 gene.
The second part of the study showed that the abnormal expression of ORMDL3 gene may be one of the causes of asthma, and the transcriptional regulation mechanism of ORMDL3 gene is still unclear, so we analyzed the basic promoter of ORMDL3 gene in this part.
Firstly, we cloned the region from the transcription starting point of ORMDL3 gene to about 1.5 KB upstream, then inserted it into the pGL3 basic vector and analyzed its promoter activity with a dual luciferase reporter gene system. Then we used a series of truncation methods to find the smallest region containing the basic promoter of ORMDL3 gene. At 62 bp, the activity of luciferase decreased by 70% to 80%, indicating that the response element affecting the activity of ORMDL3 promoter should be located between - 68 BP and - 62 bp. There is a signal transduction and activation transcription factor 6 (STAT6) binding site between - 64 BP and - 56 bp upstream of the starting point. EMSA and super shift experiments show that STAT6 can bind to the promoter of ORMDL3 gene in vitro. ChIP experiments also show that STAT6 can bind to the promoter of ORMDL3 gene in vivo.
The results showed that the basic promoter region of ORMDL3 gene was located within - 68 bp upstream of the transcription initiation point, and a signal transduction and activation transcription factor 6 (STAT6) binding site between - 64 BP and - 56 bp upstream of the transcription initiation point played a major role in the basic promoter activity of ORMDL3 gene.
The fourth part is the regulation of ORMDL3 gene expression by STAT6.
Since STAT6 binding sites in the promoter region of ORMDL3 gene play a major role in the basic promoter activity of ORMDL3 gene, how does STAT6 regulate the expression of ORMDL3 gene? For this reason, we constructed the expression vector of STAT6 and transfected STAT6 expression vector or STAT6 siRNA in Jurkat cells, respectively. It was found that high or low expression of STAT6 could significantly activate or suppress the activity of luciferase reporter gene and the expression of endogenous ORMDL3 gene mRNA in the basic promoter of ORMDL3 gene. Since STAT6 is a transcription factor regulated by cytokine IL-4/IL-13, the expression of ORMDL3 gene is also regulated by IL-4/IL-13. Therefore, we also examined the effect of IL-4/IL-13 on ORMDL3 gene expression, and found that IL-4/IL-13 treatment significantly activated the luciferase reporter gene activity of ORMDL3 gene promoter and the expression of endogenous ORMDL3 gene mRNA. Once STAT6 was interfered with, this phenomenon would disappear, indicating that IL-4/IL-13 on ORMDL3 gene expression. In addition, some studies have found that P300 can bind to the promoter of ORMDL3 gene, and its binding site is basically the same as the STAT6 binding site we found. Therefore, we carried out ChIP experiments and found that P300 can indeed bind to the promoter of ORMDL3 gene. IP experiment
【学位授予单位】:山东大学
【学位级别】:博士
【学位授予年份】:2013
【分类号】:R562.25
【相似文献】
相关期刊论文 前10条
1 邱艳红,王根娣,李云珠;哮喘儿童吸入激素治疗前后生命质量评估[J];临床儿科杂志;2001年06期
2 孔元原,孙明明;哮喘儿童行为问题研究[J];贵阳医学院学报;2001年03期
3 林茂英,任榕娜,曹惠琴,叶礼燕;哮喘儿童气质类型与社会生活能力关系的研究及干预措施[J];东南国防医药;2002年02期
4 陈洪杰,吴蓓钰,缪海中;3~13岁哮喘儿童急性发作诱因调查[J];河北医药;2003年07期
5 刘丽云,魏玉英;哮喘儿童的门诊健康教育[J];中国乡村医药;2003年04期
6 刘力行,郑菊映;持续护理干预对雾化吸入治疗小儿哮喘过程[J];现代临床医学生物工程学杂志;2005年04期
7 吴秋玲;口服单剂强的松龙治疗儿童急性哮喘[J];新医学;1988年05期
8 施毅;应用x线密度测定评价二丙酸氯地米松对哮喘儿童骨有机物含量的作用[J];国外医学.呼吸系统分册;1994年04期
9 王世荣,王光慧,崔润海,王春玲,周信英,刘友芬;哮喘儿童外周血淋巴细胞亚群与血清总IgE关系的探讨[J];天津医药;1995年01期
10 马文成,朱美华;儿童哮喘病人的TNFβ基因遗传多态性[J];现代临床医学生物工程学杂志;2005年03期
相关会议论文 前10条
1 周莹;邵洁;;家庭香烟烟雾暴露与哮喘儿童疾病控制状态相关性研究[A];中华医学会2011年全国变态反应学术会议论文集[C];2011年
2 汤正珍;刘萍;郑跃杰;;哮喘儿童吸入糖皮质激素治疗的回顾性研究[A];中华医学会2011年全国变态反应学术会议论文集[C];2011年
3 唐芙蓉;;哮喘儿童过敏原检测及早期干预[A];全国儿科护理学术交流会议论文汇编[C];2011年
4 汤正珍;郑跃杰;;哮喘儿童吸入糖皮质激素后5年过敏原变化[A];中华医学会2011年全国变态反应学术会议论文集[C];2011年
5 赵秀勉;;浅析对哮喘儿童及其家长的健康教育[A];全国儿科护理学术交流暨专题讲座会议论文汇编[C];2003年
6 黄东明;肖晓雄;骆翠媚;李岚;王克明;冯垣辉;汪叶红;崔碧云;黄桂珍;阮健;郑伯强;付四毛;;哮喘和健康儿童吸入性过敏原皮肤点刺试验的对比研究[A];中华医学会2011年全国变态反应学术会议论文集[C];2011年
7 施乐;陈伟斌;;哮喘儿童体质的研究概况[A];第28次全国中医儿科学术大会暨2011年名老中医治疗(儿科)疑难病临床经验高级专修班论文汇编[C];2011年
8 刘齐元;朱腾义;程元强;范东东;;烟草atp6基因SNP的错配碱基法检测及其与CMS的相关性[A];2010中国作物学会学术年会论文摘要集[C];2010年
9 罗荣华;王次林;;400例哮喘儿童变应原皮试结果分析[A];第一届全国变态反应学术研讨会论文汇编[C];2001年
10 陈磊;郭亦杰;周继鹏;李慕朋;王英;李元建;陈小平;;中国汉族人群DDAH1功能性SNP的研究及对ADMA代谢的影响[A];中国药理学会第十一次全国学术会议专刊[C];2011年
相关重要报纸文章 前10条
1 中国疾控中心环境所研究员 徐东群;洁净室内环境让孩子远离哮喘[N];健康报;2010年
2 健康时报记者 冯丽安 特约记者 康芳琴;治哮喘儿童时期最关键[N];健康时报;2009年
3 王山;哮喘儿童 家庭护理有学问[N];中国中医药报;2009年
4 上海岳阳中西医结合医院儿科 陈伟斌 副主任医师;哮喘儿童的日常生活保健[N];上海中医药报;2010年
5 徐铮奎;哮喘儿童不宜多吃麦淇淋[N];大众卫生报;2002年
6 黄秀清;盛夏需防“冷”过敏[N];保健时报;2003年
7 黄秀清;盛夏需防“冷”过敏[N];中国中医药报;2003年
8 记者 刘海英;公共场所禁烟惠及每一人[N];科技日报;2010年
9 北京协和医院变态反应科副主任医师 支玉香;家养宠物 难逃过敏[N];健康报;2009年
10 Marvin;测基因而知天命?[N];经济观察报;2009年
相关博士学位论文 前10条
1 邱熔芳;ORMDL3在哮喘发生中的作用及其转录调控机制研究[D];山东大学;2013年
2 李艳春;白细胞介素-23对哮喘小鼠记忆T细胞增殖功能的影响[D];吉林大学;2013年
3 周卫芳;药物和低剂量照射干预哮喘免疫调节机制的探讨[D];苏州大学;2011年
4 苏奎国;五紫三黄方对激素依赖性哮喘小鼠模型作用机理的实验研究[D];北京中医药大学;2012年
5 刘艳明;哮喘小鼠气道白细胞介素-6、信号转导和转录激活因子3的表达与活化及其作用[D];广西医科大学;2010年
6 刘绍坤;RNA干扰GATA-3基因表达对急性哮喘小鼠Th17细胞分化及致炎机能的影响[D];中南大学;2010年
7 杨沫毅;急性哮喘小鼠中T-bet通过IL-23受体对Th17细胞增殖和致炎机能的影响[D];中南大学;2010年
8 吴小慧;支气管哮喘相关基因的多态性研究[D];华中科技大学;2010年
9 田金娜;活血定喘汤对哮喘小鼠气道重塑的实验研究[D];成都中医药大学;2010年
10 迟翔宇;ADAM33基因在支气管哮喘发病中的研究[D];山东大学;2011年
相关硕士学位论文 前10条
1 黄汉琮;ORMDL3基因rs7216389位点多态性与哮喘相关性研究[D];南昌大学;2011年
2 阳爱梅;湖南省哮喘儿童ORMDL3基因多态性分析及与OPN、TGF-β1水平相关性探讨[D];中南大学;2012年
3 王倩;游戏治疗取向团体辅导在哮喘儿童心理应对能力训练中的应用[D];重庆医科大学;2011年
4 吴丹遐;恐惧应激与实验大鼠哮喘相关性的研究[D];南昌大学;2011年
5 徐同福;哮喘疾病中锌转运体表达的初步研究[D];山东大学;2010年
6 刘芳;哮喘对学龄期儿童认知功能影响的研究[D];中国医科大学;2010年
7 汤正珍;哮喘儿童吸入糖皮质激素治疗的回顾性研究[D];遵义医学院;2011年
8 胡平;哮喘儿童(7-17岁)自我管理量表的编制及应用[D];重庆医科大学;2011年
9 徐丹;哮喘黏膜免疫过程中“肺开窍于鼻”理论的体现[D];新疆医科大学;2010年
10 刘娜;学龄期哮喘儿童自我管理行为的干预效果研究[D];中国协和医科大学;2010年
,本文编号:2180431
本文链接:https://www.wllwen.com/yixuelunwen/huxijib/2180431.html